Lockheed Martin, Rockville, Md, and Illumina Inc, San Diego, recently announced a new strategic alliance to collaborate on scalable and affordable genomics solutions to provide personalized health care for national populations.
The alliance brings together Illumina’s next-generation genetic sequencing tools with Lockheed Martin’s expertise in large-scale information systems and integration to meet the needs of countries as they begin to integrate genomics into their national health systems.
“We look forward to working with Lockheed Martin and global health care leaders as we develop best-in-class solutions to realize the full potential of nation-scale sequencing,” says Jay Flatley, CEO of Illumina. “We are excited about this collaboration, given the breadth and depth of Lockheed Martin’s operations and strategic relationships around the globe.”
Genomics is the science of studying genomes or DNA. Applied to health care, analyzing a person’s DNA sequence data can provide a better understanding of health risks (such as how susceptible a person is to a particular disease or if the person may react to a type of medication), resulting in more precise and proactive medicine. By aggregating genomic data across large populations, public health and wellness officials can more effectively address health concerns, reducing health care costs and improving quality of life.
“Genomics is enabling a fundamental transformation of healthcare,” says Horace Blackman, vice president of health and life sciences for Lockheed Martin’s information systems and global solutions business. “We envision the advantages of early national adoption for countries across the globe, applying clinical decision support applications that can improve health and healthcare, and lower national healthcare costs.”
Illumina is a leader in sequencing and array-based technologies, enabling the adoption of genomic solutions in research and clinical settings. Lockheed Martin is a global security and aerospace company that is engaged in the research, design, development, manufacture, integration, and sustainment of advanced technology systems, products, and services.